|
|
|
Insider
Information: |
Baker G Leonard Jr |
Relationship: |
10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
1,066,812 |
|
Indirect Shares
|
10,825,897 |
|
|
Direct
Value |
$33,002,580 |
|
|
Indirect Value
|
$134,611,822 |
|
|
Total
Shares |
11,892,709 |
|
|
Total
Value |
$167,614,402 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
15
|
1
|
Stock
price went up :
|
10
|
1
|
Stock
price went down : |
5
|
0
|
|
|
|
Gain/Loss Ratio : |
2.0
|
1.0
|
Percentage
Gain/Loss : |
13.8%
|
72.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Mattersight Corporation |
MATR |
10% Owner |
2014-06-12 |
7,981 |
2014-06-12 |
2,633,587 |
Premium* |
|
Corcept Therapeutics Inc |
CORT |
Director |
2023-07-17 |
1,046,631 |
2023-07-17 |
4,263,565 |
Premium* |
|
Dextera Surgical Inc |
DXTR |
10% Owner |
2006-02-08 |
8,360 |
2014-01-01 |
3,790,923 |
Premium* |
|
Molecular Templates, Inc. |
MTEM |
10% Owner |
2008-08-29 |
3,840 |
2014-10-01 |
132,161 |
Premium* |
|
Quinstreet, Inc |
QNST |
10% Owner |
|
0 |
2010-02-10 |
5,661 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
174 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 7 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CORT |
Corcept Therapeutics Inc |
Director |
|
2018-11-21 |
4 |
B |
$12.73 |
$890,785 |
I/I |
70,000 |
3,044,793 |
2.1 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2019-02-12 |
4 |
B |
$11.39 |
$341,613 |
D/D |
30,000 |
996,838 |
2.39 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2019-02-12 |
4 |
B |
$11.39 |
$797,097 |
I/I |
70,000 |
3,114,793 |
2.1 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2019-06-03 |
4 |
S |
$9.78 |
$293,298 |
D/D |
(30,000) |
996,838 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2019-06-03 |
4 |
OE |
$0.96 |
$28,800 |
D/D |
30,000 |
1,026,838 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2020-05-28 |
4 |
OE |
$3.47 |
$104,100 |
D/D |
30,000 |
1,026,838 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2020-05-28 |
4 |
S |
$15.70 |
$471,060 |
D/D |
(30,000) |
996,838 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2020-08-28 |
4 |
B |
$12.48 |
$255,213 |
I/I |
20,444 |
3,135,237 |
2.1 |
% |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2020-09-01 |
4 |
B |
$12.50 |
$322,526 |
I/I |
25,807 |
3,161,044 |
2.1 |
% |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2020-11-06 |
4 |
B |
$17.98 |
$242,665 |
I/I |
13,500 |
3,174,544 |
2.1 |
% |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2020-11-09 |
4 |
B |
$17.96 |
$68,013 |
I/I |
3,786 |
3,178,330 |
2.1 |
% |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2020-11-10 |
4 |
B |
$17.71 |
$265,635 |
I/I |
15,000 |
3,193,330 |
2.1 |
% |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2020-11-13 |
4 |
B |
$17.94 |
$3,588 |
I/I |
200 |
3,193,530 |
2.1 |
% |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2020-11-17 |
4 |
B |
$17.82 |
$140,469 |
I/I |
7,883 |
3,201,413 |
2.1 |
% |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2020-11-18 |
4 |
B |
$17.91 |
$42,491 |
I/I |
2,372 |
3,203,785 |
2.1 |
% |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2020-11-23 |
4 |
B |
$22.93 |
$35,562 |
I/I |
1,551 |
3,205,336 |
2.1 |
% |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2020-11-24 |
4 |
B |
$22.93 |
$32,766 |
I/I |
1,429 |
3,206,765 |
2.1 |
% |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2020-11-25 |
4 |
B |
$22.81 |
$8,233 |
I/I |
361 |
3,207,126 |
2.1 |
% |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2020-11-30 |
4 |
B |
$22.80 |
$25,285 |
I/I |
1,109 |
3,208,235 |
2.1 |
% |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2020-12-01 |
4 |
B |
$22.64 |
$1,540 |
I/I |
68 |
3,208,303 |
2.02 |
% |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2021-05-18 |
4 |
OE |
$1.74 |
$555,000 |
D/D |
150,000 |
1,146,838 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2021-06-11 |
4 |
B |
$21.53 |
$1,076,500 |
D/D |
50,000 |
1,046,838 |
2.39 |
% |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2021-06-11 |
4 |
B |
$21.53 |
$2,153,000 |
I/I |
100,000 |
3,308,303 |
2.1 |
% |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2023-07-17 |
4 |
GD |
$0.00 |
$0 |
I/I |
0 |
3,308,303 |
0 |
- |
|
174 Records found
|
|
Page 7 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|